623 related articles for article (PubMed ID: 19614557)
1. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
[TBL] [Abstract][Full Text] [Related]
2. The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status.
van der Velden WJ; Plantinga TS; Feuth T; Donnelly JP; Netea MG; Blijlevens NM
Clin Immunol; 2010 Aug; 136(2):302-6. PubMed ID: 20452827
[TBL] [Abstract][Full Text] [Related]
3. Host-microbe interactions in stem cell transplantation: recognizing Candida in infection and inflammation.
van der Velden WJ; Plantinga TS; Donnelly JP; Kullberg BJ; Blijlevens NM; Netea MG
Virulence; 2010; 1(3):180-4. PubMed ID: 21178438
[TBL] [Abstract][Full Text] [Related]
4. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
Tollemar J; Gross N; Dolgiras N; Jarstrand C; Ringdén O; Hammarström L
Bone Marrow Transplant; 1999 Feb; 23(3):283-90. PubMed ID: 10084261
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
7. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans.
Saijo S; Fujikado N; Furuta T; Chung SH; Kotaki H; Seki K; Sudo K; Akira S; Adachi Y; Ohno N; Kinjo T; Nakamura K; Kawakami K; Iwakura Y
Nat Immunol; 2007 Jan; 8(1):39-46. PubMed ID: 17159982
[TBL] [Abstract][Full Text] [Related]
8. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
Jantunen E; Nihtinen A; Volin L; Juvonen E; Parkkali T; Ruutu T; Anttila VJ
Bone Marrow Transplant; 2004 Nov; 34(10):891-5. PubMed ID: 15517009
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
10. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
McCoy D; Depestel DD; Carver PL
Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
[TBL] [Abstract][Full Text] [Related]
11. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
13. A new step toward individualized antifungal prevention in hematopoietic stem cell transplantation.
Bochud PY; Calandra T
Clin Infect Dis; 2009 Sep; 49(5):733-5. PubMed ID: 19614558
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
16. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity.
Cunha C; Di Ianni M; Bozza S; Giovannini G; Zagarella S; Zelante T; D'Angelo C; Pierini A; Pitzurra L; Falzetti F; Carotti A; Perruccio K; Latgé JP; Rodrigues F; Velardi A; Aversa F; Romani L; Carvalho A
Blood; 2010 Dec; 116(24):5394-402. PubMed ID: 20807886
[TBL] [Abstract][Full Text] [Related]
17. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis.
Chai LY; de Boer MG; van der Velden WJ; Plantinga TS; van Spriel AB; Jacobs C; Halkes CJ; Vonk AG; Blijlevens NM; van Dissel JT; Donnelly PJ; Kullberg BJ; Maertens J; Netea MG
J Infect Dis; 2011 Mar; 203(5):736-43. PubMed ID: 21242599
[TBL] [Abstract][Full Text] [Related]
18. Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation.
Zollner-Schwetz I; Auner HW; Paulitsch A; Buzina W; Staber PB; Ofner-Kopeinig P; Reisinger EC; Olschewski H; Krause R
J Infect Dis; 2008 Jul; 198(1):150-3. PubMed ID: 18491972
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
Sohn HS; Lee TJ; Kim J; Kim D
Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
[TBL] [Abstract][Full Text] [Related]
20. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Hamza NS; Ghannoum MA; Lazarus HM
Bone Marrow Transplant; 2004 Sep; 34(5):377-89. PubMed ID: 15247928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
